Diabetic Retinopathy: Retina‐Specific Methods for Maintenance of Diabetic Rodents and Evaluation of Vascular Histopathology and Molecular Abnormalities

Alexander Veenstra1, Haitao Liu1, Chieh Allen Lee2, Yunpeng Du2, Jie Tang3, Timothy S. Kern3

1 These authors contributed equally to this work, 2 Case Western Reserve University and Case Medical Center, Cleveland, Ohio, 3 Veterans Administration Medical Center Research Service 151, Cleveland, Ohio
Publication Name:  Current Protocols in Mouse Biology
Unit Number:   
DOI:  10.1002/9780470942390.mo140190
Online Posting Date:  September, 2015
GO TO THE FULL TEXT: PDF or HTML at Wiley Online Library

Abstract

Diabetic retinopathy is a major cause of visual impairment, which continues to increase in prevalence as more and more people develop diabetes. Despite the importance of vision, the retina is one of the smallest tissues in the body, and specialized techniques have been developed to study retinopathy. This article summarizes several methods used to (i) induce diabetes in mice, (ii) maintain the diabetic animals throughout the months required for development of typical vascular histopathology, (iii) evaluate vascular histopathology of diabetic retinopathy, and (iv) quantitate abnormalities implicated in the development of the retinopathy. © 2015 by John Wiley & Sons, Inc.

Keywords: diabetes; streptozotocin; retinopathy; retina; mouse

     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Table of Contents

  • Introduction
  • Basic Protocol 1: Induction of Diabetes Using Streptozotocin
  • Basic Protocol 2: Clinical Measures of Diabetes Severity
  • Basic Protocol 3: Isolation of Fresh Retina
  • Basic Protocol 4: Isolation of Retinal Vessels for Histology
  • Basic Protocol 5: Measurement of Retinal Superoxide
  • Basic Protocol 6: Quantification of Diabetes‐Induced Adherent Leukocytes in Retinal Vasculature (Leukostasis)
  • Basic Protocol 7: Immunohistochemistry of Vasculature and Leukocytes in Retinal Whole Mounts
  • Reagents and Solutions
  • Commentary
  • Literature Cited
  • Figures
     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Materials

Basic Protocol 1: Induction of Diabetes Using Streptozotocin

  Materials
  • Mice or rats (see discussion above)
  • Streptozotocin (STZ; MP Biomedicals) solution: prepare immediately before use in citrate buffer (see below) at a concentration that will deliver 60 mg/kg body weight for mice or 55 mg/kg body weight for rats, in a volume of 200 μl citrate buffer)
  • Citrate buffer: 47 mM sodium citrate/53 mM citric acid in distilled water, pH 4.5 (may be stored frozen for 6 months)Insulin
  • For mice: Dilute NPH insulin 1:10 with diluent (provided free by Eli Lilly and Co upon request) and refrigerate
  • For rats: Use NPH insulin (Humulin; Eli Lilly and Co) undiluted
  • Animal balance
  • Additional reagents and equipment for injection of mice (Donovan and Brown, ) and measuring fasting blood glucose ( protocol 2)

Basic Protocol 2: Clinical Measures of Diabetes Severity

  Materials
  • Blood glucose test strips and glucose meter (most glucose meters will be appropriate)
  • Method to measure HbA1c (or glycated hemoglobin); we currently use the VARIANT Classic system (BioRad Clinical Diagnostics)
  • Animal balance to measure body weight.
  • Additional reagents and equipment for blood collection from rodents (Donovan and Brown, )

Basic Protocol 3: Isolation of Fresh Retina

  Materials
  • Mouse or rat (see discussion in protocol 1 introduction)
  • Small dissecting scissors (curved, blunt‐end, 22‐mm; Roboz, cat. no. RS‐5983)
  • Pink dental wax (Electron Microscopy Sciences, cat. no. 72670)
  • Dissecting microscope
  • Micro‐forceps (Dumont #5, biological‐grade tip; Electron Microscopy Sciences, cat. no. 72700‐D or Dumont, electronic‐grade tip, Electron Microscopy Sciences, cat. no. 0103‐2‐PO)
  • Razor blades (GEM single edge stainless steel, Teflon coated; Electron Microscopy Sciences, cat. no. 71970)
  • Micro‐spatula (Fine Science Tools, FST 10091‐12)
  • Micro‐dissecting spring scissors (Vannas, 3‐mm straight; Roboz, cat. no. RS‐5620)
  • Additional reagents and equipment for rodent anesthesia (Donovan and Brown, ) or euthanasia (Donovan and Brown, )

Basic Protocol 4: Isolation of Retinal Vessels for Histology

  Materials
  • Mouse or rat (see discussion in protocol 1 introduction)
  • 10% buffered formalin (Sigma, cat. no. HT501128, or equivalent)
  • Elastase solution (see recipe)
  • Activating solution (100 mM Tris·Cl, pH 8.5)
  • Periodic acid solution: 35 mM periodic acid/12 mM sodium acetate in H 2O
  • Schiff reagent base (Sigma, cat. no. 3952016)
  • Harris modified hematoxylin (Sigma‐Aldrich, cat. no. HHS128); filter before use to remove precipitates
  • 7.4 mM ammonium hydroxide
  • 70%, 80%, 95%, and 100% ethanol
  • Xylene
  • Permount mounting medium
  • Microcentrifuge tubes or 48‐well plates
  • Lid from petri dish
  • Dissecting microscope
  • Two “brushes” made from single sable hairs or cat whiskers glued to the end of glass a rod with fingernail polish (an additional brush glued at both ends of the hair to the rod so that it forms a loop is helpful (Fig. )
  • Micro‐forceps (Dumont #5, biological‐grade tip; Electron Microscopy Sciences, cat. no. 72700‐D or Dumont, electronic‐grade tip; Electron Microscopy Sciences, cat. no. 0103‐2‐PO)
  • Superfrost Plus treated microscope slides (Fisher, cat. no. 12‐550‐15; use slides from unopened box or clean as described in under step 20, below)
  • Glass transfer pipet: snap off the thin end of a Pasteur pipet (borosilicate glass, Fisher, cat. no. 1367820B), fire‐polish to remove jagged edges, and fit the “broken” end with a rubber bulb (Fisher, cat. no. 0344821)
  • Staining jars
  • 22 × 40–mm glass coverslips
  • Mounting dish (glass, ∼4‐in. radius × 1.25‐in. high, having fluid exit for water to drain out from underneath the glass microscope slide that is placed in the mounting dish while attaching the isolated vasculature to the microscope slide)
  • Additional reagents and equipment for isolating retina ( protocol 3)

Basic Protocol 5: Measurement of Retinal Superoxide

  Materials
  • Freshly isolated retina ( protocol 3)
  • Krebs‐HEPES buffer (see recipe)
  • 5 mM lucigenin (see recipe)
  • 10× cell lysis buffer (Cell Signaling, cat. no. 9803)
  • Bradford protein assay kit
  • Probe type sonicator/cell disrupter
  • Luminometer (e.g., GlowMax 20/20 from Promega)

Basic Protocol 6: Quantification of Diabetes‐Induced Adherent Leukocytes in Retinal Vasculature (Leukostasis)

  Materials
  • Saline: 0.9%, veterinary grade (Baxter, cat. no. 04925‐04‐10)
  • 1 mg/ml concanavalin A–FITC (Vector FL‐1001) in PBS (see next line)
  • Phosphate‐buffered saline (PBS; Sigma, cat. no. P3813)
  • Infusurge 4010 pressure infuser (Ethox, Inc.)
  • IV catheter set with regulating clamp (70 in., Baxter, cat. no. 2C5417s)
  • Two 4‐way stopcock luer‐lock IV line valves (Baxter, 2C6204)
  • Two IV extension sets (3.9 ml, 36 in., luer‐lock; Baxter, cat. no. 2C2667)
  • One IV extension set (2.3 ml, 21 in., Luer‐lock; Baxter, cat. no. 2C2662)
  • 0.22‐μm syringe filter
  • 20‐G gavage needle (1.25‐mm O.D. barrel tip, 30 mm length; Fine Science Tools, cat. no. 18060‐20)
  • 10‐ml syringe
  • Hemostats
  • Fluorescence microscope with FITC filter
  • Additional reagents and equipment for rodent anesthesia (Donovan and Brown, ) and isolating the retina ( protocol 3)

Basic Protocol 7: Immunohistochemistry of Vasculature and Leukocytes in Retinal Whole Mounts

  Materials
  • Concanavalin A working solution (see recipe)
  • Fixation buffer: 2% paraformaldehyde in PBS pH 7.2
  • Triton X‐100
  • Phosphate‐buffered saline (PBS; Sigma, cat. no. P3813)
  • Demasking buffer (see recipe)
  • Blocking buffer (see recipe)
  • Primary antibodies:
  • Rabbit anti‐collagen IV (1:1000 dilution; Abcam, cat. no. Ab6586)
  • Donkey anti‐Rabbit AF488 conjugated (1:1000 dilution; Jackson ImmunoResearch, cat. no. 711‐545‐152)
  • Rat IgG2b anti‐CD45 clone 30 F‐11 PE conjugated (1:500 dilution; BD, cat. no. 553081)
  • Goat Anti‐PE (1:1000 dilution; Rockland, cat. no. 600‐101‐387), pre‐labeled with Dylight 594 (Thermo Fisher, cat. no. 46412)
  • Goat anti‐Concanavalin A (1:500 dilution; Vector Labs, cat. no. AS2004), pre‐labeled with Dylight 650 (Thermo Fisher, cat. no. 62274)
  • TBST (see recipe)
  • Hoechst 3342 (1:1000 dilution Thermo Fisher Scientific, cat. no. 62249)
  • Tris‐buffered saline (TBS; optional, see recipe)
  • Antifade mounting medium
  • Microscope slide with well (see annotation to step 17)
  • Clear nail polish
  • Glass coverslips, thickness #1, 22 × 40 mm
  • Fluorescence microscope
  • Additional reagents and equipment for perfusion of mouse ( protocol 6) and isolation of the retina ( protocol 3)
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Figures

Videos

Literature Cited

Literature Cited
  Asnaghi, V., Gerhardinger, C., Hoehn, T., Adeboje, A., and Lorenzi, M. 2003. A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat. Diabetes 52:506‐511. doi: 10.2337/diabetes.52.2.506.
  Barber, A.J., Antonetti, D.A., Kern, T.S., Reiter, C.E., Soans, R.S., Krady, J.K., Levison, S.W., Gardner, T.W., and Bronson, S.K. 2005. The Ins2Akita mouse as a model of early retinal complications in diabetes. Invest. Ophthalmol. Vis. Sci. 46:2210‐2218. doi: 10.1167/iovs.04‐1340.
  Barile, G.R., Pachydaki, S.I., Tari, S.R., Lee, S.E., Donmoyer, C.M., Ma, W., Rong, L.L., Buciarelli, L.G., Wendt, T., Horig, H., Hudson, B.I., Qu, W., Weinberg, A.D., Yan, S.F., and Schmidt, A.M. 2005. The RAGE axis in early diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 46:2916‐2924. doi: 10.1167/iovs.04‐1409.
  Berkowitz, B.A., Gradianu, M., Bissig, D., Kern, T.S., and Roberts, R. 2009. Retinal ion regulation in a mouse model of diabetic retinopathy: Natural history and the effect of Cu/Zn superoxide dismutase overexpression. Invest. Ophthalmol. Vis. Sci. 50:2351‐2358. doi: 10.1167/iovs.08‐2918.
  Bogdanov, P., Corraliza, L., Villena, J. A., Carvalho, A.R., Garcia‐Arumi, J., Ramos, D., Ruberte, J., Simo, R., and Hernandez, C. 2014. The db/db mouse: A useful model for the study of diabetic retinal neurodegeneration. PLoS One 9:e97302.
  Cheung, A.K., Fung, M.K., Lo, A.C., Lam, T.T., So, K.F., Chung, S.S., and Chung, S.K. 2005. Aldose reductase deficiency prevents diabetes‐induced blood‐retinal barrier breakdown, apoptosis, and glial reactivation in the retina of db/db mice. Diabetes 54:3119‐3125. doi: 10.2337/diabetes.54.11.3119.
  Dagher, Z., Park, Y.S., Asnaghi, V., Hoehn, T., Gerhardinger, C., and Lorenzi, M. 2004. Studies of rat and human retinas predict a role for the polyol pathway in human diabetic retinopathy. Diabetes 53:2404‐2411. doi: 10.2337/diabetes.53.9.2404.
  Donovan, J. and Brown, P. 1998. Anesthesia. Curr. Protoc. Immunol. 27:1.4.1‐1.4.5.
  Donovan, J. and Brown, P. 2006a. Parenteral injections. Curr. Protoc. Immunol. 73:1.6.1‐1.6.10.
  Donovan, J. and Brown, P. 2006b. Blood collection. Curr. Protoc. Immunol. 73:1.7.1‐1.7.9.
  Donovan, J. and Brown, P. 2006c. Euthanasia. Curr. Protoc. Immunol. 73:1.8.1‐1.8.4.
  Du, Y., Veenstra, A., Palczewski, K., and Kern, T.S. 2013. Photoreceptor cells are major contributors to diabetes‐induced oxidative stress and local inflammation in the retina. Proc. Natl. Acad. Sci. U.S.A. 110:16586‐16591. doi: 10.1073/pnas.1314575110.
  Engerman, R.L. and Kern, T.S. 1987. Progression of incipient diabetic retinopathy during good glycemic control. Diabetes 36:808‐812. doi: 10.2337/diab.36.7.808.
  Engerman, R.L. and Kern, T.S. 1993. Aldose reductase inhibition fails to prevent retinopathy in diabetic and galactosemic dogs. Diabetes 42:820‐825. doi: 10.2337/diab.42.6.820.
  Engerman, R.L., Bloodworth, J.M.B. Jr, and Nelson, S. 1977. Relationship of microvascular disease in diabetes to metabolic control. Diabetes 26:760‐769. doi: 10.2337/diab.26.8.760.
  Feit‐Leichman, R.A., Kinouchi, R., Takeda, M., Fan, Z., Mohr, S., Kern, T.S., and Chen, D.F. 2005. Vascular damage in a mouse model of diabetic retinopathy: Relation to neuronal and glial changes. Invest. Ophthalmol. Vis. Sci. 46:4281‐4287. doi: 10.1167/iovs.04‐1361.
  Geraldes, P., Hiraoka‐Yamamoto, J., Matsumoto, M., Clermont, A., Leitges, M., Marette, A., Aiello, L.P., Kern, T.S., and King, G.L. 2009. Activation of PKC‐delta and SHP‐1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy. Nat. Med. 15:1298‐1306. doi: 10.1038/nm.2052.
  Gubitosi‐Klug, R.A., Talahalli, R., Du, Y., Nadler, J.L., and Kern, T.S. 2008. 5‐Lipoxygenase, but not 12/15‐Lipoxygenase, contributes to degeneration of retinal capillaries in a mouse model of diabetic retinopathy. Diabetes 57:1387‐1393. doi: 10.2337/db07‐1217.
  Hammes, H.‐P., Klinzing, I., Wiegand, S., Bretzel, R.G., Cohen, A.M., and Federlin, K. 1993. Islet transplantation inhibits diabetic retinopathy in the sucrose‐fed diabetic Cohen diabetic rat. Invest. Ophthalmol. Vis. Sci. 34:2092‐2096.
  Han, Z., Guo, J., Conley, S.M., and Naash, M.I. 2013. Retinal angiogenesis in the Ins2(Akita) mouse model of diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 54:574‐584. doi: 10.1167/iovs.12‐10959.
  Huang, H., Gandhi, J.K., Zhong, X., Wei, Y., Gong, J., Duh, E.J., and Vinores, S.A. 2011. TNFalpha is required for late BRB breakdown in diabetic retinopathy, and its inhibition prevents leukostasis and protects vessels and neurons from apoptosis. Invest. Ophthalmol. Vis. Sci. 52:1336‐1344. doi: 10.1167/iovs.10‐5768.
  Janssen, B., Debets, J., Leenders, P., and Smits, J. 2002. Chronic measurement of cardiac output in conscious mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282:R928‐R935. doi: 10.1152/ajpregu.00406.2001.
  Jiao, Y., Sun, Z., Lee, T., Fusco, F.R., Kimble, T.D., Meade, C.A., Cuthbertson, S., and Reiner, A. 1999. A simple and sensitive antigen retrieval method for free‐floating and slide‐mounted tissue sections. J. Neurosci. Methods 93:149‐162. doi: 10.1016/S0165‐0270(99)00142‐9.
  Kanwar, M., Chan, P.S., Kern, T.S., and Kowluru, R.A. 2007. Oxidative damage in the retinal mitochondria of diabetic mice: Possible protection by superoxide dismutase. Invest. Ophthalmol. Vis. Sci. 48:3805‐3811. doi: 10.1167/iovs.06‐1280.
  Kern, T.S. and Engerman, R.L. 1994. Comparison of retinal lesions in alloxan‐diabetic rats and galactose‐fed rats. Curr. Eye Res. 13:863‐867. doi: 10.3109/02713689409015087.
  Kern, T.S. and Engerman, R.L. 1995. Vascular lesions in diabetes are distributed non‐uniformly within the retina. Exp. Eye Res. 60:545‐549. doi: 10.1016/S0014‐4835(05)80069‐7.
  Kern, T.S. and Engerman, R.L. 1996. A mouse model of diabetic retinopathy. Arch. Ophthalmol. 114:986‐990. doi: 10.1001/archopht.1996.01100140194013.
  Kowluru, R.A., Tang, J., and Kern, T.S. 2001. Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long‐term administration of antioxidants on the development of retinopathy. Diabetes 50:1938‐1942. doi: 10.2337/diabetes.50.8.1938.
  Kowluru, R.A., Kowluru, A., Chakrabarti, S., and Khan, Z. 2004. Potential contributory role of H‐Ras, a small G‐protein, in the development of retinopathy in diabetic rats. Diabetes 53:775‐783. doi: 10.2337/diabetes.53.3.775.
  Krady, J.K., Basu, A., Allen, C.M., Xu, Y., LaNoue, K.F., Gardner, T.W., and Levison, S.W. 2005. Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase‐3 activation in a rodent model of diabetic retinopathy. Diabetes 54:1559‐1565. doi: 10.2337/diabetes.54.5.1559.
  Kuwabara, T. and Cogan, D.G. 1960. Studies of retinal vascular patterns: I. Normal architecture. Arch. Ophthalmol. 64:904‐911. doi: 10.1001/archopht.1960.01840010906012.
  Laver, N.M., Robison, W.G., Jr., and Pfeffer, B.A. 1993. Novel procedures for isolating intact retinal vascular beds from diabetic humans and animal models. Invest. Ophthalmol. Vis. Sci. 34:2097‐2104.
  Li, J., Wang, J.J., Chen, D., Mott, R., Yu, Q., Ma, J.X., and Zhang, S.X. 2009. Systemic administration of HMG‐CoA reductase inhibitor protects the blood‐retinal barrier and ameliorates retinal inflammation in type 2 diabetes. Exp. Eye Res. 89:71‐78.
  Li, G., Veenstra, A.A., Talahalli, R.R., Wang, X., Gubitosi‐Klug, R.A., Sheibani, N., and Kern, T.S. 2012. Marrow‐derived cells regulate the development of early diabetic retinopathy and tactile allodynia in mice. Diabetes 61:3294‐3303. doi: 10.2337/db11‐1249.
  Marliss, E.B., Nakhooda, A.F., Poussier, P., and Sima, A.A. 1982. The diabetic syndrome of the 'BB' Wistar rat: Possible relevance to type 1 (insulin‐dependent) diabetes in man. Diabetologia 22:225‐232. doi: 10.1007/BF00281296.
  McLenachan, S., Chen, X., McMenamin, P.G., and Rakoczy, E.P. 2013. Absence of clinical correlates of diabetic retinopathy in the Ins2Akita retina. Clin. Exp. Ophthalmol. 41:582‐592. doi: 10.1111/ceo.12084.
  Muir, E.R., Renteria, R.C., and Duong, T.Q. 2012. Reduced ocular blood flow as an early indicator of diabetic retinopathy in a mouse model of diabetes. Invest. Ophthalmol. Vis. Sci. 53:6488‐6494. doi: 10.1167/iovs.12‐9758.
  Nakama, K., Shichinohe, K., Kobayashi, K., Naito, K., Uchida, O., Yasuhara, K., and Tobe, M. 1985. Spontaneous diabetes‐like syndrome in WBN/KOB rats. Acta Diabet. Lat. 22:335‐342. doi: 10.1007/BF02624752.
  Ning, X., Baoyu, Q., Yuzhen, L., Shuli, S., Reed, E., and Li, Q.Q. 2004. Neuro‐optic cell apoptosis and microangiopathy in KKAY mouse retina. Int. J. Mol. Med. 13:87‐92.
  Ratner, R.E. 2001. Glycemic control in the prevention of diabetic complications. Clin. Cornerstone 4:24‐37. doi: 10.1016/S1098‐3597(01)90027‐4.
  Shinohara, M., Masuyama, T., Shoda, T., Takahashi, T., Katsuda, Y., Komeda, K., Kuroki, M., Kakehashi, A., and Kanazawa, Y. 2000. A new spontaneously diabetic non‐obese Torii rat strain with severe ocular complications. Int. J. Exp. Diabetes Res. 1:89‐100. doi: 10.1155/EDR.2000.89.
  Smith, S.B., Duplantier, J., Dun, Y., Mysona, B., Roon, P., Martin, P.M., and Ganapathy, V. 2008. In vivo protection against retinal neurodegeneration by sigma receptor 1 ligand (+)‐pentazocine. Invest. Ophthalmol. Vis. Sci. 49:4154‐4161. doi: 10.1167/iovs.08‐1824.
  Stitt, A., Gardiner, T.A., Alderson, N.L., Canning, P., Frizzell, N., Duffy, N., Boyle, C., Januszewski, A.S., Chachich, M., Baynes, J.W., Thorpe, S.R., and Anderson, N.L. 2002. The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes. Diabetes 51:2826‐2832. doi: 10.2337/diabetes.51.9.2826.
  Talahalli, R., Zarini, S., Tang, J., Li, G., Murphy, R., Kern, T.S., and Gubitosi‐Klug, R.A. 2013. Leukocytes regulate retinal capillary degeneration in the diabetic mouse via generation of leukotrienes. J. Leukoc. Biol. 93:135‐143. doi: 10.1189/jlb.0112025.
  Tang, J., Mohr, S., Du, Y., and Kern, T.S. 2003. Non‐uniform distribution of lesions and biochemical abnormalities within the retina of diabetic humans. Curr. Eye Res. 27:7‐13. doi: 10.1076/ceyr.27.2.7.15455.
  Tang, J., Du, Y., Petrash, J.M., Sheibani, N., and Kern, T.S. 2013. Deletion of aldose reductase from mice inhibits diabetes‐induced retinal capillary degeneration and superoxide generation. PLoS One 8:e62081.
  Tang, L., Zhang, Y., Jiang, Y., Willard, L., Ortiz, E., Wark, L., Medeiros, D., and Lin, D. 2011. Dietary wolfberry ameliorates retinal structure abnormalities in db/db mice at the early stage of diabetes. Exp. Biol. Med. 236:1051‐1063. doi: 10.1258/ebm.2011.010400.
  The Diabetes Control and Complications Trial Research Group. 1993. The effect of intensive treatment of diabetes on the development and progression of long‐term complications in insulin‐dependent diabetes mellitus. The diabetes control and complications trial research group. N. Engl. J. Med. 329:977‐986. doi: 10.1056/NEJM199309303291401.
  United Kingdom Prospective Diabetes Study. 1998. Intensive blood‐glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 352:837‐853. doi: 10.1016/S0140‐6736(98)07019‐6.
  Vagaja, N.N., Binz, N., McLenachan, S., Rakoczy, E.P., and McMenamin, P.G. 2013. Influence of endotoxin‐mediated retinal inflammation on phenotype of diabetic retinopathy in Ins2 Akita mice. Br. J. Ophthalmol. 97:1343‐1350. doi: 10.1136/bjophthalmol‐2013‐303201.
  Veenstra, A.A., Tang, J., and Kern, T.S. 2013. Antagonism of CD11b with neutrophil inhibitory factor (NIF) inhibits vascular lesions in diabetic retinopathy. PLoS One 8:e78405. doi: 10.1371/journal.pone.0078405.
  Xu, Z., Wei, Y., Gong, J., Cho, H., Park, J.K., Sung, E.R., Huang, H., Wu, L., Eberhart, C., Handa, J.T., Du, Y., Kern, T.S., Thimmulappa, R., Barber, A.J., Biswal, S., and Duh, E.J. 2014. NRF2 plays a protective role in diabetic retinopathy in mice. Diabetologia 57:204‐213. doi: 10.1007/s00125‐013‐3093‐8.
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library